Details for New Drug Application (NDA): 017993
✉ Email this page to a colleague
NDA 017993 describes HYDERGINE, which is a drug marketed by Novartis and is included in four NDAs. Additional details are available on the HYDERGINE profile page.
The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
The generic ingredient in HYDERGINE is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 017993
| Tradename: | HYDERGINE |
| Applicant: | Novartis |
| Ingredient: | ergoloid mesylates |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017993
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
